Lanza named head of Astellas global regenerative medicine
Lanza named head of Astellas global regenerative medicine

“Robert Lanza, one of the most prominent scientists in the field of stem cell biology, on Monday said he will lead global regenerative medicine research at Astellas Pharma Inc., the Japanese drug maker that acquired his Massachusetts company this month. Lanza will also remain in his current role of chief scientific officer at Astellas-owned Ocata Therapeutics Inc., which is developing stem cell therapies for a broad range of diseases.”